; Sareum Holdings plc (SAR) - Financial and Strategic SWOT Analysis Review
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Sareum Holdings plc (SAR) - Financial and Strategic SWOT Analysis Review

VIEWS: 32 PAGES: 34

Sareum Holdings plc (SAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Sareum Holdings plc (Sareum) is a drug discovery company. The company produces targeted small mol

More Info
  • pg 1
									            Sareum Holdings plc (SAR) - Financial and Strategic SWOT Analysis
                                         Review
        Reference Code: GDPH82356FSA                                                                                                                          Publication Date: JAN 2014

       Table of Contents
       Table of Contents ............................................................................................................................................................................... 1
          List of Tables .................................................................................................................................................................................. 2
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 5
       Sareum Holdings plc - Key Facts ....................................................................................................................................................... 5
       Sareum Holdings plc - Key Employees .............................................................................................................................................. 6
       Sareum Holdings plc - Key Employee Biographies ............................................................................................................................ 7
       Sareum Holdings plc - Major Products and Services ......................................................................................................................... 8
       Sareum Holdings plc - Pharmaceutical Pipeline Products Data ......................................................................................................... 9
          Sareum Holdings plc, Pipeline Products by Therapy Area.............................................................................................................. 9
          Sareum Holdings plc, Pipeline Products by Development Phase ................................................................................................. 10
       Sareum Holdings plc - History .......................................................................................................................................................... 13
       Sareum Holdings plc - Locations And Subsidiaries .......................................................................................................................... 15
          Head Office ................................................................................................................................................................................... 15
          Other Locations & Subsidiaries ..................................................................................................................................................... 15
       Section 2 – Company Analysis ......................................................................................................................................................... 16
       Sareum Holdings plc - Business Description .................................................................................................................................... 16
       Sareum Holdings plc - SWOT Analysis ............................................................................................................................................ 17
          SWOT Analysis - Overview........................................................................................................................................................... 17
          Sareum Holdings plc - Strengths .................................................................................................................................................. 17
             Strength - In-house Research Expertise ................................................................................................................................... 17
             Strength - Agreements & Collaboration ..................................................................................................................................... 17
             Strength - Increasing Liquidity ................................................................................................................................................... 17
          Sareum Holdings plc - Weaknesses ............................................................................................................................................. 17
             Weakness - Lack of Commercial Products................................................................................................................................ 17
          Sareum Holdings plc - Opportunities ............................................................................................................................................ 18
             Opportunity - Market Potential: Cancer ..................................................................................................................................... 18
             Opportunity - Growing Market Opportunities in Emerging Markets ........................................................................................... 18
             Opportunity - New Developments ............................................................................................................................................. 18
          Sareum Holdings plc - Threats ..................................................................................................................................................... 18
             Threat - Increasing Competitive Pressures ............................................................................................................................... 18
             Threat - Stringent Government Regulations .............................................................................................................................. 19
       Sareum Holdings plc - Key Competitors ........................................................................................................................................... 20
       Section 3 – Company Financial Ratios ............................................................................................................................................. 21
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 21
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 21
       Performance Chart ........................................................................................................................................................................... 22
       Financial Performance...................................................................................................................................................................... 22
       Financial Ratios - Interim Ratios....................................................................................................................................................... 23
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 24
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 25


Sareum Holdings plc (SAR) - Financial and Strategic SWOT                                                                                                       Reference Code: GDPH82356FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          Sareum Holdings plc, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 ........................................................... 25
          Sareum Holdings plc, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 .......................................................... 26
       Sareum Holdings plc, Recent Deals Summary................................................................................................................................. 27
       Section 5 – Company’s Recent Developments ................................................................................................................................ 28
          Sareum Holdings plc, Recent Developments................................................................................................................................ 28
             Apr 24, 2013: Sareum To Receive £150,000 Research Grant From UK Technology Strategy Board ...................................... 28
             Feb 18, 2013: Sareum Provides Update On Cancer And Auto-immune Disease Research Programs ..................................... 28
       Section 6 – Appendix ....................................................................................................................................................................... 30
          Methodology ................................................................................................................................................................................. 30
          Ratio Definitions ............................................................................................................................................................................ 30
          About GlobalData ......................................................................................................................................................................... 34
          Contact Us .................................................................................................................................................................................... 34
          Disclaimer ..............................................................................................................
								
To top